HEADER HORMONE 02-APR-12 4APD TITLE LIRAGLUTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIRAGLUTIDE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GLUCAGON-LIKE PEPTIDE 1(7-37); COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: LIRAGLUTIDE IS A HUMAN GLP-1 ANALOG SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS HORMONE, GLUCAGON, GLUCAGON LIKE PEPTIDE-1 ANALOG EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.LUDVIGSEN,D.B.STEENSGAARD,J.K.THOMSEN,H.STRAUSS,M.NORMANN REVDAT 3 14-JUN-23 4APD 1 REMARK LINK ATOM REVDAT 2 29-JAN-14 4APD 1 COMPND SOURCE DBREF SEQADV REVDAT 1 10-JUL-13 4APD 0 JRNL AUTH D.B.STEENSGAARD,J.K.THOMSEN,H.STRAUSS,M.NORMANN,S.LUDVIGSEN JRNL TITL LIRAGLUTIDE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR 3.1, CNX CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4APD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-APR-12. REMARK 100 THE DEPOSITION ID IS D_1290051960. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300.0 REMARK 210 PH : 7.9 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 10% D2O / 90% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : PRONTO, X-PLOR, CNX REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: TOCSY AND NOESY DATA FOR ASSIGMENT AND MODEL BUILDING. REMARK 210 STRUCTURE IS COMPOSED OF 2 HELICES WHICH ARE POORLY ORIENTED REMARK 210 RELATIVE TO EACH OTHER REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 12 -47.63 -169.95 REMARK 500 1 GLN A 23 -78.89 -90.33 REMARK 500 1 ALA A 25 -73.55 -54.29 REMARK 500 1 ARG A 34 55.27 -106.19 REMARK 500 1 ARG A 36 38.38 -161.01 REMARK 500 2 PHE A 12 -42.20 -138.71 REMARK 500 2 LEU A 20 -76.82 -72.01 REMARK 500 2 GLU A 21 -73.40 -147.72 REMARK 500 2 ARG A 34 78.19 -112.39 REMARK 500 3 GLU A 21 121.04 -174.63 REMARK 500 4 PHE A 12 -43.12 -135.30 REMARK 500 5 PHE A 12 -84.21 -163.71 REMARK 500 5 THR A 13 -71.08 -94.70 REMARK 500 5 LEU A 20 69.98 -68.79 REMARK 500 5 GLU A 21 -74.73 -123.23 REMARK 500 5 ARG A 34 -75.25 -110.30 REMARK 500 6 PHE A 12 -59.26 -158.91 REMARK 500 6 SER A 18 -60.54 -90.42 REMARK 500 6 GLU A 21 160.85 60.26 REMARK 500 7 PHE A 12 -41.75 -170.19 REMARK 500 7 GLU A 21 -67.85 69.06 REMARK 500 7 LYS A 26 -32.15 -38.74 REMARK 500 7 ARG A 34 70.86 -109.04 REMARK 500 8 PHE A 12 -42.31 -169.96 REMARK 500 8 ARG A 36 34.20 -98.66 REMARK 500 9 THR A 11 91.19 -69.81 REMARK 500 9 PHE A 12 -35.01 -155.66 REMARK 500 9 ARG A 36 149.41 -172.15 REMARK 500 10 PHE A 12 -42.10 -170.02 REMARK 500 10 LEU A 20 -84.43 -76.00 REMARK 500 10 GLU A 21 -63.65 169.60 REMARK 500 10 ARG A 36 28.40 47.94 REMARK 500 11 ALA A 8 109.70 -166.79 REMARK 500 11 PHE A 12 -50.89 -165.42 REMARK 500 11 GLU A 21 -78.99 -60.61 REMARK 500 11 PHE A 28 -71.50 -53.80 REMARK 500 11 ILE A 29 -19.26 -45.90 REMARK 500 11 ARG A 36 -73.52 66.31 REMARK 500 12 THR A 11 -175.46 -69.83 REMARK 500 12 PHE A 12 -39.59 -170.12 REMARK 500 12 LEU A 20 -177.99 -55.07 REMARK 500 12 GLU A 21 -72.14 -135.44 REMARK 500 12 ARG A 34 31.42 -98.52 REMARK 500 12 ARG A 36 -70.58 -130.84 REMARK 500 13 PHE A 12 -45.57 -137.12 REMARK 500 13 GLU A 21 45.76 -96.27 REMARK 500 13 ARG A 36 112.90 61.05 REMARK 500 14 GLU A 9 -177.89 -69.97 REMARK 500 14 PHE A 12 -42.36 -132.52 REMARK 500 14 GLU A 21 83.18 44.04 REMARK 500 REMARK 500 THIS ENTRY HAS 69 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 LYS(GAMMA-GLU-PALMITOYL) (D6M): POSITION 26 IS REMARK 600 LYSINE-GAMMA-GLU-PALMITOYL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D6M A 1038 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18378 RELATED DB: BMRB REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN POSITION 26 LYSINE IS MODIFIED WITH LYS(GAMMA-GLU- REMARK 999 PALMITOYL) DBREF 4APD A 7 37 UNP P01275 GLUC_HUMAN 98 128 SEQADV 4APD ARG A 34 UNP P01275 LYS 125 ENGINEERED MUTATION SEQRES 1 A 31 HIS ALA GLU GLY THR PHE THR SER ASP VAL SER SER TYR SEQRES 2 A 31 LEU GLU GLY GLN ALA ALA LYS GLU PHE ILE ALA TRP LEU SEQRES 3 A 31 VAL ARG GLY ARG GLY HET D6M A1038 63 HETNAM D6M N-HEXADECANOYL-L-GLUTAMIC ACID FORMUL 2 D6M C21 H39 N O5 HELIX 1 1 THR A 13 TYR A 19 1 7 HELIX 2 2 ALA A 24 ARG A 34 1 11 LINK NZ LYS A 26 C07 D6M A1038 1555 1555 1.33 SITE 1 AC1 7 ALA A 25 LYS A 26 PHE A 28 ILE A 29 SITE 2 AC1 7 TRP A 31 LEU A 32 VAL A 33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1